ASTAGRAF XL (Astellas Pharma US, Inc.)
Welcome to the PulseAid listing for the ASTAGRAF XL drug offered from Astellas Pharma US, Inc.. This Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Astellas Pharma US, Inc. |
| NON-PROPRIETARY NAME: | tacrolimus extended-release capsules |
| SUBSTANCE NAME: | TACROLIMUS |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, COATED, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-07-19 |
| END MARKETING DATE: | 0000-00-00 |
ASTAGRAF XL HUMAN PRESCRIPTION DRUG Details:
| Item Description | ASTAGRAF XL from Astellas Pharma US, Inc. |
| LABELER NAME: | Astellas Pharma US, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.5(mg/1) |
| START MARKETING DATE: | 2013-07-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0469-0647_0efc0fec-ca65-4b14-ac98-40be39d5ac27 |
| PRODUCT NDC: | 0469-0647 |
| APPLICATION NUMBER: | NDA204096 |
Other TACROLIMUS Pharmaceutical Manufacturers / Labelers:
